Van Staa et al identified risk factors for vertebral fractures in a patient being treated with oral glucocorticoid therapy. This can help identify a patient who may require closer monitoring or a change in therapy to reduce the risk. The authors are from the University of Southampton, Utrecht University, University Center Nijmegen, St. Paul Medical Center (Dallas), University of Aberdeen, and Proctor & Gamble Pharmaceuticals.

To read more or access our algorithms and calculators, please log in or register.